Development of StaphVAX(TM), a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials

Author： Fattom A.I. Horwith G. Fuller S. Propst M. Naso R.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.22, Iss.7, 2004-02, pp. : 880-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine

By Baker C.J. Rench M.A. McInnes P.

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3468-3472

Elsevier

Access to resources Recommend Favorite

Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain

By Salleras L. Domnguez A. Cardenosa N.

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 725-728

Elsevier

Access to resources Recommend Favorite

Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharides

By Flanagan M.P. Michael J.G.

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 72-81

Elsevier

Access to resources Recommend Favorite

Some important issues in the planning of phase III HIV vaccine efficacy trials

By Boily M.-C. Masse B.R. Desai K. Alary M. Anderson R.M.

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 989-1004

Elsevier

Access to resources Recommend Favorite

Polysaccharide-iron-regulated cell surface protein conjugate vaccine: its role in protection against Klebsiella pneumoniae-induced lobar pneumonia

By Chhibber S. Bajaj J.

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 179-184

Elsevier

Access to resources Recommend Favorite